Aberrant p53 Expression Predicts Clinical Resistance to Cisplatin-based Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer

Valerie Rusch, Nael Martini, David Klimstra, Julie Oliver, Ennapadam Venkatraman, Mark Kris, Ethan Dmitrovsky, Valerie Rusch, Ethan Dmitrovsky, Ethan Dmitrovsky, Richard Gralla

Research output: Contribution to journalArticlepeer-review

180 Scopus citations

Fingerprint

Dive into the research topics of 'Aberrant p53 Expression Predicts Clinical Resistance to Cisplatin-based Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences